63 /100
HIGH RISK
Score updated May 30, 2026

ESLA — Estrella Immunopharma, Inc. Dilution Risk Tracker

Track ESLA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ESLA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
57
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
40%
📉 Score Deterioration 50%
• Score rose 37 points recently (worsening)
• Score in HIGH risk zone (63/100)
🔄 Reverse Split 40%
• 50-day avg $1.37 approaching $1 threshold
• 8 months cash with weak price
💰 Capital Raise 15%
• Under 12 months cash (8mo)
🔔 Track ESLA — Get forecast alerts →

💹 Market Data

Market Cap$46.91M
Shares Outstanding43.03M
Float14.11M
Cash$1.93M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

12.2% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track ESLA for full holder detail →

📉 Short Interest

Short Interest94.1K
Days to Cover2.7
% of Float0.7%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Jun 30, 2023
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track ESLA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ESLA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for ESLA
📊 ESLA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ESLA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.